Detalles de la búsqueda
1.
Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study.
Blood
; 119(26): 6219-25; quiz 6399, 2012 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-22442350
2.
High-dose imatinib versus high-dose imatinib in combination with intermediate-dose cytarabine in patients with first chronic phase myeloid leukemia: a randomized phase III trial of the Dutch-Belgian HOVON study group.
Ann Hematol
; 92(8): 1049-56, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23572137
3.
A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma.
Blood
; 115(6): 1113-20, 2010 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-19880501
4.
Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival.
Haematologica
; 100(12): e508-10, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26341740
5.
Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study.
J Clin Oncol
; 28(19): 3160-6, 2010 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20516439
Resultados
1 -
5
de 5
1
Próxima >
>>